Treating intestine with 'good' cholesterol compound inhibits lung tumor growth in mice

June 14, 2018, University of California, Los Angeles
Space-filling model of the Cholesterol molecule. Credit: RedAndr/Wikipedia

A compound that mimics the main protein in high-density lipoprotein (HDL, or "good") cholesterol significantly reduced the number of tumors in the lungs of mice, reports a team of UCLA researchers. The findings help explain the connection between HDL cholesterol and reduced cancer risk, and suggest that a similar compound may be an effective therapy in humans.

Previous research, both in lab animals and humans, had suggested that higher HDL cholesterol levels were linked to reduced . The team's earlier work had found that small peptide "mimetics," or mimics, of an HDL protein reduced tumor growth in mice, but it wasn't totally clear which immune and genetic mechanisms were responsible for the connection. In the new study, the researchers set out to determine whether and how the compound, called Tg6F, might alter the immune system both in the intestine and in a distant organ (in this case, the lung).

The team used a mouse model of lung cancer, injecting into the tail veins of mice. The cancerous cells migrate to the lungs, where they grow into tumors. One group of mice was given Tg6F orally, starting the day after they were injected with cancer cells, along with their regular mouse food; another group of mice received an inactive version of the compound.

After four weeks of treatment, the number of tumor nodules was significantly lower in the lungs of Tg6F-fed mice—on average, 75 percent lower than controls.

The team also looked at how the compound was exerting its anti-cancer effects, and found that Tg6F altered lipid metabolism in the , which in turn altered gene expression and the type of immune cells present in both the intestine and the lung. In particular, the Tg6F supplements increased the expression of genes in a pathway that boosts patrolling for cancer, and decreased gene expression in a pathway that facilitates cancer growth.

The findings illuminate the mechanisms by which "good" cholesterol may reduce cancer risk, and underscore how important the small intestine is in exerting immune effects in distant organs. The results suggest that oral compounds may have therapeutic value for treating in humans. The team next plans to look at whether Tg6F also inhibits in other organs of the body.

The study was published in Scientific Reports, a Nature journal.

Explore further: When push comes to shove: Airway cells propel liver cancer spread to lungs

More information: Arnab Chattopadhyay et al. Treating the Intestine with Oral ApoA-I Mimetic Tg6F Reduces Tumor Burden in Mouse Models of Metastatic Lung Cancer, Scientific Reports (2018). DOI: 10.1038/s41598-018-26755-0

Related Stories

When push comes to shove: Airway cells propel liver cancer spread to lungs

June 4, 2018
Hepatocellular carcinoma (HCC) is the most common form of liver cancer, and the third biggest cause of death from cancer worldwide. Although HCC patients have benefited from recent improvements in diagnoses and various therapies, ...

Reducing cholesterol could enhance T-cell cancer immunotherapy

May 16, 2018
Cleveland Clinic researchers have demonstrated for the first time that lowering blood cholesterol levels could enhance the success of a specific type of T-cell immunotherapy in fighting cancer.

Study could explain link between high-cholesterol diet and colon cancer

January 25, 2018
New UCLA research could help explain the link between a high-cholesterol diet and an elevated risk for colon cancer.

RNA-based therapeutic inhibits a metabolic pathway in tumor-initiating lung cancer cells

March 23, 2018
RNA-based therapeutics that prevent a key metabolic enzyme from being expressed in tumor-initiating cells (TIC) hold promise for the treatment of lung cancer, an A*STAR team has shown.

Cholesterol byproduct hijacks immune cells, lets breast cancer spread

October 12, 2017
High cholesterol levels have been associated with breast cancer spreading to other sites in the body, but doctors and researchers don't know the cause for the link. A new study by University of Illinois researchers found ...

Can mice really mirror humans when it comes to cancer?

January 18, 2018
A new Michigan State University study is helping to answer a pressing question among scientists of just how close mice are to people when it comes to researching cancer.

Recommended for you

Biologists discover how pancreatic tumors lead to weight loss

June 20, 2018
Patients with pancreatic cancer usually experience significant weight loss, which can begin very early in the disease. A new study from MIT and Dana-Farber Cancer Institute offers insight into how this happens, and suggests ...

Researchers find 11 genes responsible for the spread of cancer

June 20, 2018
A groundbreaking discovery by University of Alberta researchers has identified previously-unknown therapeutic targets that could be key to preventing the spread of cancer.

'Kiss of death' cancer: How computational geeks may have uncovered a therapy for a deadly disease

June 19, 2018
It's called the 'kiss of death'. Triple negative breast cancer has no targeted drug therapy and, as such, the only hope for these patients is chemotherapy. Triple negative breast cancer is aggressive and deadly. Patients ...

Ovarian cancer cells switched off by 'unusual' mechanism

June 19, 2018
Scientists at the Ovarian Cancer Action Research Centre at Imperial College London have discovered a mechanism that deactivates ovarian cancer cells.

Team discovers gene mutations linked to pancreatic cancer

June 19, 2018
Six genes contain mutations that may be passed down in families, substantially increasing a person's risk for pancreatic cancer. That's according to Mayo Clinic research published in the June 19 edition of the JAMA. However, ...

Breast cancer could be prevented by targeting epigenetic proteins, study suggests

June 19, 2018
Researchers at the Princess Margaret Cancer Centre in Toronto have discovered that epigenetic proteins promote the proliferation of mammary gland stem cells in response to the sex hormone progesterone. The study, which will ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.